PX trades 105.3% below Wall Street's consensus target of $15.50.
Last 12 months price action with 12-month analyst target path
The base valuation assumes PX achieves its forward estimates and maintains a stable P/E multiple of 6.9x. This scenario reflects the blended consensus of 8 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of September 23, 2026, P10, Inc. (PX) has a Wall Street consensus price target of $15.50, based on estimates from 8 covering analysts. With the stock currently trading at $7.55, this represents a potential upside of +105.3%. The company has a market capitalization of $909M.
Analyst price targets range from a low of $12.00 to a high of $25.00, representing a 84% spread in expectations. The median target of $12.50 differs from the mean, suggesting potential outlier estimates. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 4 analysts rating the stock as a Buy or Strong Buy,3 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, PX trades at a trailing P/E of 47.2x and forward P/E of 6.9x. The forward PEG ratio of 0.05 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow -91.8% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $464.70, with bear and bull scenarios of $292.76 and $612.28 respectively. Model confidence stands at 47/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 AMGAffiliated Managers Group, Inc. | $9.5B | $360.28 | $410.00 | +13.8% | Buy | 9.8x | 12 |
 STEPStepStone Group Inc. | $6.0B | $46.57 | $65.14 | +39.9% | Buy | 22.3x | 8 |
 HLNEHamilton Lane Incorporated | $4.9B | $87.60 | $131.60 | +50.2% | Buy | 14.5x | 10 |
 GCMGGCM Grosvenor Inc. | $2.5B | $13.23 | $17.00 | +28.5% | Buy | 14.7x | 8 |
 ARESAres Management Corporation | $41.0B | $124.72 | $149.33 | +19.7% | Buy | 21.3x | 22 |
 BXBlackstone Inc. | $97.7B | $124.01 | $145.89 | +17.6% | Buy | 20.6x | 30 |
 KKRKKR & Co. Inc. | $88.4B | $98.44 | $126.78 | +28.8% | Buy | 14.9x | 27 |
 APOApollo Global Management, Inc. | $71.5B | $124.15 | $145.00 | +16.8% | Buy | 14.2x | 28 |
 CGThe Carlyle Group Inc. | $14.5B | $40.23 | $56.71 | +41.0% | Buy | 11.0x | 26 |
 TPGTPG Inc. | $17.5B | $45.62 | $58.88 | +29.1% | Buy | 16.0x | 18 |
Quick answers to the most common questions about buying PX stock.
The consensus Wall Street price target for PX is $15.5, representing 105.3% upside from the current price of $7.55. With 8 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
PX has a consensus rating of "Buy" based on 8 Wall Street analysts. The rating breakdown is mixed, with 3 Hold ratings making up the largest segment. The consensus 12-month price target of $15.5 implies 105.3% upside from current levels.
With a forward P/E of 6.9247x, PX trades at a relatively low valuation. The consensus target of $15.5 implies 105.3% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $25 for PX, while the most conservative target is $12. The consensus of $15.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $612 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
PX is moderately covered, with 8 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 3 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month PX stock forecast based on 8 Wall Street analysts shows a consensus price target of $15.5, with estimates ranging from $12 (bear case) to $25 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $465, with bear/bull scenarios of $293/$612.
Our quantitative valuation model calculates PX's fair value at $465 (base case), with a bear case of $293 and bull case of $612. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 47/100.
PX trades at a forward P/E ratio of 6.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 47.2x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on PX, with a "Buy" consensus rating and $15.5 price target (105.3% upside). 4 of 8 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
PX analyst price targets range from $12 to $25, a 84% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $15.5 consensus represents the middle ground. Our model's $293-$612 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.